RxDoctor Payments Data

Ginger Greene, APRN

Family · Murray, KYNPI 1235379173

Payments from drug & device makers

$962in general payments, 2019–2025

Across 43 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$206
  • Astellas Pharma US Inc$165
  • Boston Scientific$122
  • 180 Medical, Inc.$112
  • Boehringer Ingelheim$98
  • Johnson & Johnson$85
  • plus $175 from 4 others

What the payments were for

  • Food & beverage$77881%
  • Education$18419%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$962 in reported general payments places this provider in the 60th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$96,379
Medicare patients
589
Services billed
2,410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron95$56,950
MyrbetriqMirabegron75$54,648
Tamsulosin Hcl735$10,337
Mirabegron ErMirabegron14$9,537
Finasteride703$8,683
Potassium Citrate ErPotassium Citrate91$7,501
Dutasteride207$7,331
Cephalexin328$3,363
Estradiol52$3,347
Alfuzosin Hcl ErAlfuzosin Hcl77$1,738
Trospium Chloride ErTrospium Chloride13$1,520
Solifenacin Succinate33$1,149
Trospium Chloride14$1,136
Doxycycline Hyclate98$1,106
Oxybutynin Chloride ErOxybutynin Chloride59$1,080

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$206$56,95095 claims
Astellas Pharma US IncMyrbetriq$165$54,64875 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,374 family providers in Kentucky.

Other family in Murray

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →